Leadership Team

Foto: Dr. Erich Tauber

Dr. Erich Tauber
Chief Executive Officer, Co-Founder
Erich Tauber is co-founder and has been CEO of Themis since its inception.

He entered the pharmaceutical and biotech industry in 2000, and served in roles with increasing responsibility at AstraZeneca, Baxter, Intercell and Nycomed. He is an expert in vaccine development and has substantial experience in the clinical and regulatory field.

He received academic training at the University of Vienna, University of Southampton, WU Executive Academy Vienna, and received his habilitation for Clinical Pharmacology at the Medical University of Vienna. Before joining the industry, he completed his medical degree as a Pediatrician.


Foto: Dr. David A. Maier

Dr. David A. Maier
Chief Financial Officer

David A. Maier joined Themis Bioscience 2015 and acts as a CFO for the company.

David attended a chemical technical college and studied business administration at WU Wien with focus on finance and controlling. After working a few years for a Big 4 audit firm he managed a local private equity fund in Austria and held several positions on supervisory board level at portfolio companies.     Afterwards he co-founded a company and acted as CFO in the company.

Beside his finance position at Themis he has specialised in company valuation and acts also as an expert witness in this field. Additionally, he is a lecturer at the university of applied science (FH Wien) and publishes specialist articles concerning valuation and finance.


Katrin Ramsauer

Dr. Katrin Ramsauer

Head of Preclinical and Clinical Development

Katrin Ramsauer joined Themis in 2010 as Senior Scientist Vaccine Development. Since 2013 she heads Themis preclinical and clinical development advancing the companies lead program in Chikungunya through a successful Phase 1 study. Prior to Themis she was a postdoctoral scientist at Novartis Vaccine and Diagnostics Inc. in Cambridge, MA where she investigated the mechanisms of action of vaccine candidates and small molecule compounds. Dr. Ramsauer also held postdoctoral fellowship positions at the Clinical Institute of Virology, Medical University of Vienna and Max F. Perutz Laboratories, University of Vienna. She holds a PhD in molecular biology and immunology and a master in microbiology from the University of Vienna.


Fotos: Dr. Matthias Müllner

Dr. Matthias Müllner

Head of CMC

Matthias Müllner has been leading Themis CMC efforts since 2013, developing a scalable and robust manufacturing process. He joined Themis in 2011 as Senior Scientist Vaccine development from the Children’s Cancer Research Institute (CCRI), Vienna. In his postdoctoral scientist position he developed treatments against adenoviral infections of immunocompromised patients. He is a lecturer at the university of applied science (FH Wien) and holds a PhD and a master degree in molecular biology from the University of Vienna.


Foto: Alexander Kort

Alexander Kort

Head of Business Processes and Quality

Alexander Kort is the Head of Business Process and Quality. He joined Themis in 2016 from IDT Biologika GmbH, where he served in roles of increasing responsibility including Project Manager, Contract Manufacturing Human Viral Vaccines, Head of Project Management, Contract Manufacturing Human Viral Vaccines and Senior Expert Project Management, Strategic Projects Operations. During his tenure at IDT Biologika he led several vaccine projects, establishing processes and workflows from R&D to industrial manufacturing including scale-up, process validation and site readiness. Mr Kort completed his degree in Biosystems Engineering at the University of Magdeburg, Germany.